ClinConnect ClinConnect Logo
Search / Trial NCT06522347

Mycobacteria Registry Study: Prospective Observational Study in Austria

Launched by LUDWIG BOLTZMANN INSTITUTE FOR LUNG HEALTH · Jul 22, 2024

Trial Information

Current as of August 29, 2025

Recruiting

Keywords

Mycobacterium Tuberculosis Nontuberculous Mycobacteria Mycobacterium Infections

ClinConnect Summary

This clinical trial, known as the Mycobacteria Registry Study, is focused on understanding the risk factors that can lead to serious health issues or death from infections caused by Mycobacterium tuberculosis (the bacteria that causes tuberculosis) and non-tuberculous mycobacteria (other related bacteria). The goal of the study is to gather information about patients' experiences and treatment outcomes as they receive their usual medical care. By collecting this data, researchers hope to learn more about how effective current treatments are and what factors might put patients at greater risk.

To participate in this study, individuals must be at least 18 years old and diagnosed with either tuberculosis or a non-tuberculous mycobacterial infection. Importantly, participants will not receive any additional treatments from the study; instead, the focus is on observing their ongoing care. If you're eligible and choose to take part, you'll be helping to provide valuable insights that can improve understanding and treatment for these infections in Austria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
  • individuals aged 18 years or older
  • written informed consent
  • Exclusion Criteria:
  • to not comprehend and rightfully judge participation

About Ludwig Boltzmann Institute For Lung Health

The Ludwig Boltzmann Institute for Lung Health is a leading research institution dedicated to advancing the understanding and treatment of respiratory diseases. With a strong focus on translational research, the Institute integrates clinical and laboratory studies to develop innovative therapies and improve patient outcomes. Collaborating with a network of academic, clinical, and industry partners, the Institute aims to bridge the gap between scientific discovery and clinical application, fostering a multidisciplinary approach to lung health research. Through its commitment to excellence and innovation, the Ludwig Boltzmann Institute is at the forefront of addressing complex challenges in respiratory medicine.

Locations

Vienna, , Austria

Vienna, , Austria

Vienna, , Austria

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported